Skip to main content
Clinical Trials/EUCTR2014-003874-17-IT
EUCTR2014-003874-17-IT
Active, not recruiting
Phase 1

Antiretroviral Pre-exposure prophylaxis for natural conception (PrEP-C) in serodiscordant female partners of HIV-infected men in sustained virologic suppression

ational Institute for Infectious Diseases Lazzaro Spallanzani IRCCS0 sites30 target enrollmentSeptember 26, 2014

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
ational Institute for Infectious Diseases Lazzaro Spallanzani IRCCS
Enrollment
30
Status
Active, not recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 26, 2014
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Sponsor
ational Institute for Infectious Diseases Lazzaro Spallanzani IRCCS

Eligibility Criteria

Inclusion Criteria

  • Age\> 18 years (couple)
  • HIV infected male partner on ARV treatment with plasma HIV RNA \<40 copies / mL for at least 6 months
  • Test HIVAb / Ag negative (female partner)
  • No unprotected sex with HIV infected partner (female partner) or with other partners (couple) in the last 30 days
  • Absence of sexually transmitted disease or infection (couple)
  • Signing of Informed Consent (couple).
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 30

Exclusion Criteria

  • Female partner:
  • Hepatitis B or nephropathy
  • Presence of contraindications for Truvada as specified in the leaflet indications
  • Use of psychoactive substances that may interfere with the patient's adherence to the prescribed medication regimen
  • Participation in other Clinical Trial
  • Subjects who, in the opinion of the investigator, does not ensure appropriate adherence to the study
  • Inability to sign the informed consent.
  • Signature of consent only by the female partner.

Outcomes

Primary Outcomes

Not specified

Similar Trials